Reaction
Mycobacterium Haemophilum Infection reporting signals
As of the last recalculation, Mycobacterium Haemophilum Infection appears in 251 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 178.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 23 | 178.4 | 178.8 |
| Rifampin | 24 | 150.6 | 150.9 |
| Everolimus Tablets | 26 | 143.3 | 143.5 |
| Mycophenolate Mofetil | 117 | 132.9 | 133.0 |
| Mycophenolate Mofetil Hydrochloride | 117 | 132.7 | 132.8 |
| Sirolimus | 14 | 91.2 | 91.3 |
| Tacrolimus Ointment 0.1% | 87 | 88.1 | 88.2 |
| Tacrolimus Extended-Release Capsules | 87 | 87.9 | 88.0 |
| Thiotepa | 7 | 62.5 | 62.5 |
| Clarithromycin | 23 | 61.1 | 61.1 |
| Mycophenilic Acid | 13 | 54.8 | 54.8 |
| Everolimus | 26 | 47.2 | 47.2 |